GPGI Q1 2026 Earnings EPS Misses Estimates by 5351 as Stock Gains 385 Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations QFIN Q4 2025 Earnings EPS Miss Triggers Share Price Decline QTTB Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress SEVN Q1 2026 Earnings Slight EPS Beat Amidst Market Headwinds ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues